M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 425 JPY -0.87% Market Closed
Market Cap: 967.6B JPY
Have any thoughts about
M3 Inc?
Write Note

M3 Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

M3 Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M3 Inc
TSE:2413
Accrued Liabilities
ÂĄ23.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EM Systems Co Ltd
TSE:4820
Accrued Liabilities
ÂĄ429m
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
7%
S
Software Service Inc
TSE:3733
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medley Inc
TSE:4480
Accrued Liabilities
ÂĄ685m
CAGR 3-Years
34%
CAGR 5-Years
63%
CAGR 10-Years
N/A
JMDC Inc
TSE:4483
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
e
eWeLL Co Ltd
TSE:5038
Accrued Liabilities
ÂĄ127.3m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

M3 Inc
Glance View

Market Cap
967.6B JPY
Industry
Health Care

M3 Inc., a pioneering force in healthcare information services, has carved a niche for itself by leveraging deep insights and technological innovation to enhance medical communication and research. Founded in Japan in 2000, the company developed a robust platform that connects healthcare professionals with pharmaceutical companies, facilitating the efficient flow of information and ensuring that practitioners have access to the latest medical advancements. This focus on bridging the gap between industry players not only streamlines the dissemination of critical knowledge but also fosters a collaborative ecosystem that drives continuous medical education and patient care improvements. With a blend of data analytics and a vast network of professionals, M3 Inc. has successfully positioned itself as a go-to partner for both healthcare providers and drug manufacturers. As the company expanded its operations internationally, it adopted a strategic vision that includes significant investments in technology and data management. M3 Inc. caters to a diverse range of needs within the healthcare sector, from market research to digital marketing solutions. The firm’s innovative approach has led to impressive growth in revenue and a solid market presence across Asia and beyond. For investors, M3 Inc. represents a compelling opportunity, as its business model is designed to capitalize on the ongoing digital transformation of the healthcare industry. With a commitment to delivering substantial value and a clear growth trajectory, M3 Inc. stands poised to play an integral role in shaping the future of healthcare communication and innovation.

Intrinsic Value
2 281.17 JPY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is M3 Inc's Accrued Liabilities?
Accrued Liabilities
23.1B JPY

Based on the financial report for Sep 30, 2024, M3 Inc's Accrued Liabilities amounts to 23.1B JPY.

Back to Top